What is the appropriate acute and secondary management of a cerebrovascular accident (stroke)?

Management of Cardiovascular Accident (Stroke)

Acute Ischemic Stroke Management

For acute ischemic stroke, immediately administer IV tenecteplase (or alteplase) within 4.5 hours of symptom onset if eligible, followed by mechanical thrombectomy for large vessel occlusions within the extended time windows now supported by evidence. 1

Hyperacute Phase: Reperfusion Therapy

Thrombolytic Therapy:

• Administer IV thrombolysis with tenecteplase or alteplase within 4.5 hours of symptom onset for eligible patients, with tenecteplase emerging as the preferred agent based on recent evidence 2, 1
• Aspirin should NOT be given as a substitute for thrombolysis in otherwise eligible patients—this is harmful 3
• Delay aspirin administration for 24 hours after IV thrombolysis to reduce hemorrhagic risk 3

Mechanical Thrombectomy:

• Perform endovascular thrombectomy with stent retrievers for large vessel occlusions in both anterior and posterior circulation strokes 2, 1
• Mechanical thrombectomy is strongly recommended over intra-arterial thrombolysis as first-line therapy for large vessel occlusions 3
• The time windows for thrombectomy have expanded significantly beyond the traditional 6-hour window, with patient selection now based on advanced imaging criteria rather than rigid time cutoffs 2, 1

Blood Pressure Management in Acute Phase

For patients NOT receiving reperfusion therapy:

• Avoid routine BP lowering unless SBP ≥220 mmHg or DBP ≥120 mmHg 4
• If BP reduction is needed, lower by only 15% within the first 24 hours—aggressive lowering can worsen outcomes 4

For patients receiving IV thrombolysis or thrombectomy:

• Maintain BP <185/110 mmHg before treatment initiation 4
• Keep BP <180/105 mmHg during the first 24 hours post-treatment 3, 4
• Use micro-infusion calcium channel blockers as preferred parenteral agents for acute BP control 4

Antiplatelet Therapy in Acute Phase

Standard Ischemic Stroke:

• Administer aspirin 160-300 mg within 24-48 hours of stroke onset (not within 24 hours if thrombolysis given) 3
• Use rectal or nasogastric routes if the patient cannot swallow safely 3

Minor Stroke or High-Risk TIA:

• Initiate dual antiplatelet therapy (aspirin plus clopidogrel) within 24 hours for 21 days in patients with minor stroke—this significantly reduces early recurrent stroke risk up to 90 days 3
• Do NOT use ticagrelor over aspirin in acute minor stroke—it provides no benefit 3

Contraindicated Agents:

• Avoid glycoprotein IIb/IIIa receptor antagonists (abciximab, eptifibatide, tirofiban) in acute ischemic stroke—these are potentially harmful 3

Acute Hemorrhagic Stroke (ICH) Management

For intracerebral hemorrhage, rapidly but carefully lower SBP to approximately 140 mmHg, avoiding overshoot and excessive variability, particularly when baseline SBP exceeds 220 mmHg. 4

Blood Pressure Control in ICH

• Target SBP of approximately 140 mmHg with careful titration to avoid precipitous drops 4
• Avoid large BP variability and excessive early declines—these worsen outcomes 4
• Exercise particular caution when baseline SBP >220 mmHg, as overly aggressive reduction can cause harm 4

Secondary Prevention and Long-Term Management

Diagnostic Evaluation

Perform comprehensive workup to identify stroke mechanism:

• ECG immediately to detect atrial fibrillation (found in 7.7% of acute stroke patients) and acute MI (present in 3% of stroke presentations) 3
• Noninvasive vascular imaging (CTA, MRA, or carotid ultrasound) to identify carotid stenosis—avoid digital subtraction angiography as initial test due to 0.3-3.0% stroke risk 3
• Laboratory evaluation including CBC, troponin, PT/PTT, glucose, HbA1c, creatinine, and lipid profile 3
• Consider Lp(a) testing at least once in young stroke patients (age ≤60), as elevated Lp(a) >50 mg/dL is present in 1 in 5 individuals and is a genetically determined stroke risk factor 5

Blood Pressure Management (Chronic Phase)

Target BP <130/80 mmHg for long-term secondary prevention after both ischemic stroke and ICH 3, 4

Preferred antihypertensive agents:

• Thiazide diuretics, ACE inhibitors, or angiotensin receptor blockers as foundational therapy 4
• Calcium channel blockers are appropriate alternatives 4
• Reserve beta-blockers for specific indications (e.g., concurrent coronary disease, heart failure) 4

Lipid Management

Control lipids aggressively as part of comprehensive risk factor modification—this has proven efficacy in reducing recurrent stroke 3

Anticoagulation Considerations

The role of urgent anticoagulation remains uncertain in most acute ischemic stroke scenarios, and decisions must weigh individual thrombotic versus hemorrhagic risk 3

Critical Pitfalls to Avoid

• Never substitute aspirin for thrombolysis or thrombectomy in eligible patients—this denies proven life-saving therapy 3
• Never lower BP aggressively in acute ischemic stroke without reperfusion therapy unless severely elevated (≥220/120 mmHg)—this can extend infarct size 4
• Never give dual antiplatelets routinely to all stroke patients—reserve for minor stroke only 3
• Never delay imaging and evaluation to determine stroke mechanism—early identification of carotid stenosis and atrial fibrillation enables specific interventions that dramatically reduce recurrence risk 3